Fu, C.; Deng, L.; Zhu, X.; Wang, B.; Hu, B.; Xue, H.; Zeng, Q.; Zhang, Y.
Empagliflozin Attenuates Liver Inflammation and Fibrosis in NAFLD: Evidence from Mendelian Randomization and Mouse Experiments. Curr. Issues Mol. Biol. 2025, 47, 846.
https://doi.org/10.3390/cimb47100846
AMA Style
Fu C, Deng L, Zhu X, Wang B, Hu B, Xue H, Zeng Q, Zhang Y.
Empagliflozin Attenuates Liver Inflammation and Fibrosis in NAFLD: Evidence from Mendelian Randomization and Mouse Experiments. Current Issues in Molecular Biology. 2025; 47(10):846.
https://doi.org/10.3390/cimb47100846
Chicago/Turabian Style
Fu, Chao, Lijiao Deng, Xiaochan Zhu, Bin Wang, Bin Hu, Huan Xue, Qingxuan Zeng, and Yi Zhang.
2025. "Empagliflozin Attenuates Liver Inflammation and Fibrosis in NAFLD: Evidence from Mendelian Randomization and Mouse Experiments" Current Issues in Molecular Biology 47, no. 10: 846.
https://doi.org/10.3390/cimb47100846
APA Style
Fu, C., Deng, L., Zhu, X., Wang, B., Hu, B., Xue, H., Zeng, Q., & Zhang, Y.
(2025). Empagliflozin Attenuates Liver Inflammation and Fibrosis in NAFLD: Evidence from Mendelian Randomization and Mouse Experiments. Current Issues in Molecular Biology, 47(10), 846.
https://doi.org/10.3390/cimb47100846
